GALWAY, Ireland, June 12, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced MiniMed as the name for the planned New Diabetes Company following the intended separation. The name honors the company's roots, reflecting its original name prior to its acquisition by Medtronic in 2001, and a deep 40-year history of being at the forefront of transforming diabetes care around the world.   Key Payton with his wife Cheri Payton "Our journey began in 1983, w ...

(Photo Illustration by Cheng Xin/Getty Images)Getty ImagesDeal OverviewOn May 21, 2025, Medtronic plc (NYSE: MDT; $87.44, Market Capitalization: $112.1 billion), a global leader in medical technology, announced its intent to spin off its Diabetes business into a standalone entity (New Diabetes Company). This strategic move is designed to streamline Medtronic’s portfolio, sharpen its focus on high-margin growth areas, and unlock shareholder value.Post spin-off, Medtronic (RemainCo) will continue to operate a ...

iREIT+HOYA Capital is the premier income-focused investing service on Seeking Alpha. Our focus is on income-producing asset classes that offer the opportunity for sustainable portfolio income , diversification , and inflation hedging . Get started with a Free Two-Week Trial and take a look at our top ideas across our exclusive income-focused portfolios.It’s a great time to be an income investor, with many names trading at well above average dividend yields. While it may be tempting some high-yielding stocks ...

Over the past few years, Medtronic (MDT 0.80%) has faced significant challenges, including a pandemic-induced slowdown, relatively slow revenue growth, and economic issues that impacted its financial results. Throughout it all, Medtronic's diabetes care business has consistently been one of its fastest-growing segments.However, the healthcare leader recently announced some news regarding this unit that might surprise some investors. Let's find out more about it and discuss what it means for Medtronic's pros ...

公司业务结构 - 公司业务分为三大组合 每个组合规模约100亿美元 具备规模优势 [4][5] - 三大业务组合均以品类领导地位和技术差异化作为核心特征 [5] - 糖尿病业务已宣布将分拆 具体细节将在后续讨论中披露 [4] 技术创新 - 公司强调创新驱动增长 各业务线均拥有显著技术差异化优势 [5] - 技术差异化体现在多个品类领导品牌和特许经营权组合中 [5] 投资者沟通 - 会议采用线上问答形式 投资者可通过指定渠道实时提交问题 [2] - 公司演示材料已通过在线渠道及二维码方式提供 [3]

Medtronic (MDT) FY 2025 Conference May 29, 2025 11:00 AM ET Speaker0 yet? Alright. Very good. Well, thanks so much, guys. We're I'm Lee Hambright, med tech analyst at Bernstein. We're very happy to host Medtronic today. We have CEO, Jeff Martha, and CFO, Thierry Pierre Tatpieton. Just a reminder that investors can submit questions at any time through Pigeonhole. We'll try to work in as many as possible. Jeff's gonna kick us off with a few opening remarks. So, please take it away. Speaker1 Alright. Thanks, e ...

A quarter of a century of increasing dividends is a hell of a way to generate some passive income. Enter Dividend Aristocrats.These companies have kept increasing their dividends for at least 25 consecutive years, even during economic downturns, the recession, and the recent pandemic, and they show signs of strength today amidst all the trade-war uncertainties.We analyzed five prominent names in an underrated sector to see which one stands out the most. The winner: Medtronic (NYSE: MDT).Why the healthcare s ...

I assigned a ‘Buy’ rating to Medtronic (NYSE: MDT ) in March 2025, highlighting strength in cardiac ablation solutions. I think the company’s decision to spin off its diabetes business is a near-term catalyst for its stock price. I am upgradingAnalyst’s Disclosure: I/we have a beneficial long position in the shares of MDT either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seekin ...

GALWAY, Ireland, May 23, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it will participate in Bernstein's 41st Strategic Decisions Conference on Thursday, May 29, 2025.Geoff Martha, Medtronic chairman and chief executive officer, will make a formal presentation beginning at 11:00 a.m. EDT (10:00 a.m. CDT). Immediately following the presentation, Martha will be joined by Thierry Piéton, Medtronic executive vice president and chief financial officer, ...

Medtronic (MDT -4.12%) has been a dividend stalwart for decades. The medical device maker recently raised its dividend payment, extending its growth streak to 48 straight years. That means it is two years away from joining dividend royalty as a Dividend King. The increase pushed the healthcare company's dividend yield further above 3%, which is more than double the S&P 500's sub-1.5% dividend yield. With a growing business and a healthy financial profile, Medtronic is an excellent option for investors seeki ...